Vitiligo Support International Inc. (VSI) is a patient driven 501(c)(3) nonprofit organization offering a comprehensive resource of vitiligo education, research and awareness for those whose lives have been affected by vitiligo.

We are here to address your questions and concerns and help you connect with our community. You will find the hope, support and healing that can only be offered by those who understand best - those who have walked in your shoes.



VSI COMMUNITY
COMMUNITY LOGIN REQUIRED

Login ID:
Password:
 

Having trouble or forgotten your password? Just go here!

NEWS & UPDATES
04/01/09 - Spring 2009 Newsletter

The Spring 2009 Newsletter is now available online!

Newsletter Archives:
Winter 2008
Summer 2008
Spring 2008

RECENT ARTICLES
New Research Approach Can Potentially Stop Vitiligo in its Tracks
Written by Source: Loyola University Health System
About 1 million Americans suffer a skin disorder called vitiligo, which causes unsightly white patches on the face, hands and other parts of the body. A Loyola University Hospital researcher has won a five-year, $1.7 million federal grant to investigate a new way to treat vitiligo. This research also could point the way to new treatments for melanoma, the deadliest form of skin cancer. More...
The American Academy of Pediatrics (AAP) Doubles the Amount of Vitamin D it Recommends for Infants, Children and Adolescents
Written by The American Academy of Pediatrics (AAP) News Room
BOSTON - The American Academy of Pediatrics (AAP) is doubling the amount of vitamin D it recommends for infants, children and adolescents. The new clinical report, "Prevention of Rickets and Vitamin D Deficiency in Infants, Children, and Adolescents," recommends all children receive 400 IU a day of vitamin D, beginning in the first few days of life. The previous recommendation, issued in 2003, called for 200 IU per day beginning in the first two months of life. More...
RECENT DISCUSSIONS
Products and Services for Vitiligo
 
   
 
Copyright © 2009 Vitiligo Support International, Inc.